[Incorrect treatment of patients with allergic disorders].
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000627:therapeutic use*; D000707:Anaphylaxis / Q000139:chemically induced*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D052179:Antigens, Plant / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D003888:Desensitization, Immunologic / Q000009:adverse effects; D004338:Drug Combinations / Q000009:adverse effects; D005976:Glutaral / Q000009:adverse effects; D006801:Humans; D007223:Infant; D010936:Plant Extracts; D011058:Pollen / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D012130:Respiratory Hypersensitivity / Q000628:therapy*; D014221:Triamcinolone / Q000009:adverse effects / Q000031:analogs & derivatives; D014443:Tyrosine / Q000009:adverse effects
D000485:Allergens; D000900:Anti-Bacterial Agents; D052179:Antigens, Plant; D001993:Bronchodilator Agents; D004338:Drug Combinations; D010936:Plant Extracts; D014221:Triamcinolone; D014443:Tyrosine; C014155:Parietaria judaica pollen; D011433:Propranolol; C030262:triamcinolone diacetate; D005976:Glutaral
O nieprawidłowościach w leczeniu chorych z zaburzeniami alergicznymi.